Oramed Pharmaceuticals Inc.

ORMP · NASDAQ
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Assets
Cash & Equivalents$15,797$74,516$54,420$42,104
Short-Term Investments$82,143$56,128$87,510$100,196
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,086$832$1,291$474
Total Curr. Assets$99,026$131,476$143,221$142,774
Property Plant & Equip (Net)$3,478$2,234$1,112$1,204
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$56,611$9,530$10,911$21,071
Tax Assets$0$0$0$0
Other NC Assets$2,569$4,299$34$32
Total NC Assets$62,658$16,063$12,057$22,307
Other Assets$0$0$0$0
Total Assets$161,684$147,539$155,278$165,081
Liabilities
Payables$715$509$789$4,995
Short-Term Debt$264$181$216$243
Tax Payable$344$3,788$3,204$0
Deferred Revenue$1,236$0$0$0
Other Curr. Liab.$1,134$1,014$1,476$35
Total Curr. Liab.$3,693$5,492$5,685$5,273
LT Debt$648$120$156$186
Deferred Rev, NC$3,724$2,000$4,000$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$36$33$90$4,100
Total NC Liab.$4,408$2,153$4,246$4,286
Other Liabilities$0$0$0$0
Cap. Leases$912$301$372$429
Total Liabilities$8,101$7,645$9,931$9,559
Equity
Pref Stock$0$0$0$0
Common Stock$491$491$480$484
Retained Earnings-$170,970-$184,258-$176,616-$166,427
AOCI$0$0$0$0
Other Equity$325,008$324,579$644,802$322,384
Total Equity$154,529$140,812$146,265$156,441
Supplemental Information
Minority Interest-$946-$918-$918-$919
Total Liab. & Tot. Equity$161,684$147,539$155,278$165,081
Net Debt-$14,885-$74,215-$54,048-$41,675